Published in Am J Hum Genet on July 01, 1998
Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol (2006) 3.73
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci U S A (2001) 2.09
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer (2001) 1.44
Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation. Genetics (2008) 1.33
Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res (2009) 1.29
Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res (2003) 1.25
Cancer evolution and individual susceptibility. Integr Biol (Camb) (2011) 1.15
Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet (2011) 1.12
Heritable breast cancer in twins. Br J Cancer (2002) 1.05
Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol (2007) 1.05
Hereditary breast cancer in Jews. Fam Cancer (2004) 0.99
Classification of Missense Mutations of Disease Genes. J Am Stat Assoc (2005) 0.99
Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population. Am J Hum Genet (2001) 0.98
What are genes "for" or where are traits "from"? What is the question? Bioessays (2009) 0.94
Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2008) 0.94
Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. J Med Genet (2000) 0.88
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. Br J Cancer (2000) 0.87
Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer. Am J Hum Genet (1999) 0.86
Population-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer Genes. J Am Stat Assoc (2005) 0.85
The importance of a family history of breast cancer in predicting the presence of a BRCA mutation. Am J Hum Genet (1999) 0.83
A high frequent BRCA1 founder mutation identified in the Greenlandic population. Fam Cancer (2009) 0.83
Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell Int (2013) 0.81
BRCA1 and BRCA2 testing: weighing the demand against the benefits. Am J Hum Genet (1999) 0.81
Genetically determined subdivision of human populations with respect to the risk of breast cancer in women. Dokl Biol Sci (2006) 0.80
A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services. Br J Cancer (2006) 0.80
Why should primary care physicians know about breast cancer genetics? West J Med (2001) 0.79
Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics. PLoS One (2013) 0.79
Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil. Genet Mol Biol (2012) 0.79
Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil. Breast Cancer Res (2001) 0.75
Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model. PLoS One (2016) 0.75
Genetics through a primary care lens. West J Med (2001) 0.75
Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers. J Clin Oncol (2015) 0.75
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994) 9.60
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 9.06
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet (1991) 7.87
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Cancer statistics, 1997. CA Cancer J Clin (1997) 5.22
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet (1996) 4.36
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet (1994) 4.15
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet (1994) 3.38
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med (1996) 3.07
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med (1996) 3.04
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet (1996) 2.93
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet (1996) 2.82
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA (1995) 2.50
Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet (1996) 2.40
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
Jewish religion and risk of breast cancer. Lancet (1996) 2.14
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet (1995) 1.75
Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. Am J Hum Genet (1996) 1.72
Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol (1994) 1.59
A simplified procedure for developing multiplex PCRs. Genome Res (1995) 1.40
Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet (1995) 1.32
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res (1996) 1.21
Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet (1996) 1.04
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev (2001) 2.87
Silicone breakdown and capsular synovial metaplasia in textured-wall saline breast prostheses. Plast Reconstr Surg (1994) 2.82
Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science (1985) 2.77
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
Galactofuranose biosynthesis in Escherichia coli K-12: identification and cloning of UDP-galactopyranose mutase. J Bacteriol (1996) 1.95
Stage 0 to stage III breast cancer in young women. J Am Coll Surg (2000) 1.93
Multidisciplinary management of Hunter syndrome. Pediatrics (2009) 1.76
Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res (1995) 1.75
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N Engl J Med (2001) 1.73
Three pathways for trehalose biosynthesis in mycobacteria. Microbiology (2000) 1.73
A research agenda for gastrointestinal and endoscopic surgery. Surg Endosc (2007) 1.72
Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci U S A (1993) 1.71
Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst (2000) 1.68
Organochlorine exposures and breast cancer risk in New York City women. Environ Res (2000) 1.67
Awareness and attitudes concerning BRCA gene testing. Ann Surg Oncol (1999) 1.62
Logistic regression model for analyzing extended haplotype data. Genet Epidemiol (1998) 1.61
Epithelioid cells in myoid hamartoma of the breast: a potential diagnostic pitfall for core biopsies. Arch Pathol Lab Med (1996) 1.58
Paneth cell-like metaplasia of the prostate gland. Arch Pathol Lab Med (1992) 1.51
Somatic allelic deletion of nm23 in human cancer. Cancer Res (1991) 1.50
Cholesterol and obesity as prognostic factors in breast cancer. Cancer (1981) 1.47
Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest (1989) 1.44
Systemic inflammatory disorder related to fibrous breast capsules after silicone implant removal. Plast Reconstr Surg (1993) 1.41
Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg (1994) 1.38
Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA. Carcinogenesis (1988) 1.37
Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease. Genomics (1992) 1.35
Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci U S A (1991) 1.32
Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg (1997) 1.32
Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res (1993) 1.32
Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol (2001) 1.28
Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. J Investig Med (2000) 1.27
Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography. Anal Biochem (1996) 1.27
Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. Carcinogenesis (1995) 1.25
Breast cancer risk and environmental exposures. Environ Health Perspect (1997) 1.23
Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg (1984) 1.21
The consequence of undertreating breast cancer in the elderly. J Am Coll Surg (2001) 1.20
Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet (1993) 1.16
Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci U S A (1988) 1.15
Carcinogen macromolecular adducts and their measurement. Carcinogenesis (2000) 1.14
Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis (1994) 1.11
Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg (1999) 1.11
Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase. Ann Surg (1981) 1.11
Effects of electrical stimulation-induced leg training on skeletal muscle adaptability in spinal cord injury. Scand J Med Sci Sports (2002) 1.11
Paternal uniparental disomy for chromosome 14: a case report and review. Am J Med Genet (1997) 1.10
Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res (1992) 1.10
Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg (1986) 1.09
Perioperative blood transfusion has prognostic significance for breast cancer. Surgery (1985) 1.09
Complete removal of nonpalpable breast malignancies with a stereotactic percutaneous vacuum-assisted biopsy instrument. J Am Coll Surg (1999) 1.09
Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev (1998) 1.04
Combined high-performance liquid chromatography/32P-postlabeling assay of N7-methyldeoxyguanosine. Cancer Res (1990) 1.04
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol (2014) 1.03
p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.03
Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev (1993) 1.03
Transformation of Escherichia coli with plasmid deoxyribonucleic acid: calcium-induced binding of deoxyribonucleic acid to whole cells and to isolated membrane fractions. J Bacteriol (1981) 1.02
Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet (1993) 1.01
Biosynthetic origin of mycobacterial cell wall arabinosyl residues. J Bacteriol (1995) 1.00
Fabry disease: fourteen alpha-galactosidase A mutations in unrelated families from the United Kingdom and other European countries. Eur J Hum Genet (1996) 1.00
The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Invest (1998) 1.00
Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Lett (2000) 1.00
Simultaneous transformation of Escherichia coli by pairs of compatible and incompatible plasmid DNA molecules. Mol Gen Genet (1979) 0.99
Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Cancer Res (1990) 0.99
Ethnic differences in risk and prognostic factors for breast cancer. Cancer (1995) 0.99
CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 0.99
Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease. Mol Med (1999) 0.99
Intrauterine detection of cystic fibrosis. Pediatrics (1980) 0.99
Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype. J Hum Genet (2001) 0.98
Age distribution of right- and left-sided colorectal cancers. Am J Gastroenterol (1982) 0.97
Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency. Am J Hum Genet (1994) 0.97
A program to help major league baseball players quit using spit tobacco. J Am Dent Assoc (1994) 0.96
Pulmonary involvement in Fabry disease. Am J Respir Crit Care Med (1997) 0.95
Laparoscopic resection of two liver hemangiomata. Surg Laparosc Endosc (1995) 0.95
Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation. Can Assoc Radiol J (1999) 0.95
Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev (1993) 0.94
Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol (2001) 0.94
Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States. Cancer Lett (2001) 0.94
Oral effects of smokeless tobacco use by professional baseball players. Adv Dent Res (1997) 0.93
Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med (1992) 0.91
High intensity exercise: a cause of lymphocyte apoptosis? Biochem Biophys Res Commun (1998) 0.91
Unnecessary blood transfusions in elective colorectal cancer surgery. Transfusion (1985) 0.90
Specific detection of DNA and RNA targets using a novel isothermal nucleic acid amplification assay based on the formation of a three-way junction structure. Nucleic Acids Res (2001) 0.90
Biomonitoring of United States Army soldiers serving in Kuwait in 1991. Cancer Epidemiol Biomarkers Prev (1998) 0.90
Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surg (1986) 0.90
The risk of perforation when children with possible appendicitis are observed in the hospital. Surg Gynecol Obstet (1992) 0.90
Species-specific detection of hydrocarbon-utilizing bacteria. J Microbiol Methods (1999) 0.89
Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer. Int J Cancer (1990) 0.89
The significance of family history for patients with carcinoma of the breast. J Am Coll Surg (1994) 0.89
Fecal steroid metabolites and breast cancer risk. Cancer (1982) 0.88
Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis (1989) 0.88